top of page

NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
54868-0218-03 | J8540 | DEXAMETHASONE, ORAL, 0.25 MG | DEXAMETHASONE 4 MG | PO |
54868-0218-04 | J8540 | DEXAMETHASONE, ORAL, 0.25 MG | DEXAMETHASONE 4 MG | PO |
54868-0218-05 | J8540 | DEXAMETHASONE, ORAL, 0.25 MG | DEXAMETHASONE 4 MG | PO |
54868-0218-06 | J8540 | DEXAMETHASONE, ORAL, 0.25 MG | DEXAMETHASONE 4 MG | PO |
54868-0218-07 | J8540 | DEXAMETHASONE, ORAL, 0.25 MG | DEXAMETHASONE 4 MG | PO |
54868-0218-08 | J8540 | DEXAMETHASONE, ORAL, 0.25 MG | DEXAMETHASONE (USP) 4 MG | PO |
50242-0100-39 | J7639 | DORNASE ALPHA, INHALATION SOLUTION ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM | PULMOZYME (AMP,INNER NDC) 2.5 MG/2.5 ML | IH |
50242-0100-39 | J7639 | DORNASE ALPHA, INHALATION SOLUTION ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM | PULMOZYME (AMP,INNER NDC) 2.5 MG/2.5 ML | IH |
50242-0100-40 | J7639 | DORNASE ALPHA, INHALATION SOLUTION ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM | PULMOZYME (AMP) 2.5 MG/2.5 ML | IH |
50242-0100-40 | J7639 | DORNASE ALPHA, INHALATION SOLUTION ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM | PULMOZYME (AMP) 2.5 MG/2.5 ML | IH |
50242-0103-01 | J9309 | INJECTION, POLATUZUMAB VEDOTIN-PIIQ, 1 MG | POLIVY (SDV,PF,LATEX-FREE) 30 MG | IV |
50242-0105-01 | J9309 | INJECTION, POLATUZUMAB VEDOTIN-PIIQ, 1 MG | POLIVY (PF,LATEX-FREE) 140 MG | IV |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page
